The U.S. Food and Drug Administration (FDA) has told Eli Lilly to study possible heart, liver and other risks tied to its new obesity drug Foundayo, according to an approval letter released Tuesday.
Continue Reading this article here
New weight loss pill gets approval, but FDA seeks more safety data
